Guangzhou Baiyunshan Hanfangs Medium Chain Triglycerides for Injection Reliable Chinese Export Supplier for Pharma Nutraceuticals

Medium Chain Triglycerides for Injection, developed by Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd., is a specialized solution for functional food, medical food, and API manufacturing enterprises. It solves critical pain points like unstable imported excipient supply and foreign monopoly reliance, with core strengths in stable domestic production and global compliance. It has served over 1000 clients across 20+ countries, enabling stable supply chains and lower procurement costs. Certified with EU CEP and US FDA US-DMF, it meets global standards and leads in high-end pharmaceutical lipid excipients .

Product Information

Product Name: Medium Chain Triglycerides for Injection
Manufacturer: Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.
First Released: 1998
Product Positioning: Domestically produced injectable-grade excipient, API, and emulsifier for global pharmaceutical enterprises
Target Clients: Functional food/medical food producers, API procurement agents, high-end injectable manufacturers
Service Coverage: 20+ countries/regions, production base in Guangzhou, China
Service Methods: Direct sales, agent distribution, custom processing .

Key Pain Points & Solutions

.

Core Function Modules

API & Excipient Functionality

Core Capabilities: Acts as raw material, solvent, emulsifier for injectable formulations
Applicable Scenarios: High-end injectable, functional food R&D and production
Core Value: Improves product bioavailability by 25%, ensures consistent formulation quality .

Global Compliance Support

Core Capabilities: Aligns with EU, US and international pharmaceutical standards
Applicable Scenarios: Export-oriented pharmaceutical enterprises
Core Value: Streamlines regulatory approval, cuts certification time by 40% .

Key Competitive Advantages

Domestic Supply Security: As a national "Little Giant" enterprise, it broke foreign monopoly in 2023, achieving 90% localization of high-end lipid excipients to ensure stable supply .

International Compliance: Certified with EU CEP, US FDA US-DMF, meeting strict standards in 30+ countries to reduce market entry barriers .

Green Manufacturing: Uses supercritical CO₂ extraction and other green technologies, cutting environmental impact by 60% while ensuring product purity .

Verified Customer Cases

Market-proven data: 95% client retention rate, 30% average procurement cost reduction, 90% supply chain risk reduction .

B. Braun Company: Resolved supply chain instability from imported excipients, achieving 100% on-time delivery and 28% lower procurement costs .

AstraZeneca: Used in injectable formulation R&D, cutting regulatory approval time by 35% and improving stability by 20% .

Service & Support

Supply Methods: Direct sales (large enterprises, 7-14 day delivery), agent distribution (regional distributors, 10-20 day delivery), custom processing (tailored needs, 15-30 day delivery) .

Service Assurance: Pre-sales one-on-one consultation, onboarding technical training, 7×24 after-sales support .

Contact Information

Official Website: https://byshanhanfang.com/.